Poly Medicure P/E Ratio
Poly Medicure P/E ratio. Poly Medicure (POLYMED) P/E ratio is 53.07 (High), EPS (TTM) ₹31.79, current price ₹1619.60 on NSE vs historical average P/E of 40.99 (71.4th percentile) — Very High - High growth expectations or significantly overvalued. Examine Poly Medicure quarterly earnings for recent quarterly revenue, profit and EPS trends.
Current Valuation Metrics
Valuation Signal
Sector Context
Earnings Breakdown (TTM)
POLYMED P/E Ratio — Valuation Signal & Historical Context
Poly Medicure P/E 53.07 vs historical average 40.99, range 16.02–78.43 — signal: Overvalued. For live price, revenue and the complete fundamental profile, see Poly Medicure screener.
- Stock appears overvalued with PE of 53.07, suggesting caution for new investments
- Current PE is 29.5% above historical average
Poly Medicure P/E Ratio Historical Trend
POLYMED annual price-to-earnings ratio — 7 years, EPS and year-end price. Current P/E 53.07 vs historical average 40.99. Also explore POLYMED share price charts to track price trends across different timeframes.
POLYMED Historical P/E Ratio — EPS, Year-End Price & Valuation
Poly Medicure annual P/E ratio, EPS (₹), year-end price and valuation category on NSE.
| Year | P/E Ratio | EPS (₹) | Year-end Price (₹) | Exchange | Valuation |
|---|---|---|---|---|---|
| 2025 | 78.43 | 34.17 | ₹2679.90 | NSE | High |
| 2024 | 45.47 | 32.32 | ₹1469.65 | NSE | High |
| 2023 | 34.97 | 25.93 | ₹906.85 | NSE | High |
| 2022 | 58.88 | 16.32 | ₹960.95 | NSE | High |
| 2021 | 32.3 | 15.77 | ₹509.35 | NSE | High |
| 2020 | 16.02 | 13.57 | ₹217.35 | NSE | Moderate |
| 2019 | 20.83 | 10.73 | ₹223.50 | NSE | Moderate |
POLYMED vs Healthcare Peers — P/E Ratio Comparison
Poly Medicure P/E 53.07 vs Healthcare average 56.38, median 31.61 — range 2.04–740.29.
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Sunrest Lifescience | SUNREST | 2.04 | ₹65 | Low |
| Murae Organisor | MURAE | 2.86 | ₹41 | Low |
| Phaarmasia | PHRMASI | 3.41 | ₹63 | Low |
| Sun Pharma Advanced Rese… | SPARC | 4.29 | ₹6,582 | Low |
| Dipna Pharmachem | DPL | 4.57 | ₹12 | Low |
| JFL Life Sciences | JFLLIFE | 4.88 | ₹66 | Low |
| Kabra Drugs | KABRADG | 6.09 | ₹44 | Low |
| GKB Ophthalmics | GKB | 6.27 | ₹33 | Low |
| Royal Sense | ROYAL | 6.58 | ₹47 | Low |
| Colinz Laboratories | COLINZ | 6.62 | ₹18 | Low |